On March 11, 2021 Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, reported that Dr. Ivor Royston, President and Chief Executive Officer of Viracta will present at the Oppenheimer 31st Annual Healthcare Conference taking place virtually from March 16-18, 2021 (Press release, Viracta Therapeutics, MAR 11, 2021, View Source [SID1234576553]). Viracta’s management team will also be available for one-on-one investor meetings at the conference.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Presentation details can be found below.
Date:
Tuesday, March 16, 2021
Time:
2:30 p.m. ET
Webcast Link:
A replay of the presentation will be archived for 90 days on the "Events and Webcasts" section of the Viracta website at View Source